Jefferies Maintains Humana(HUM.US) With Buy Rating, Maintains Target Price $419
Wolfe Research Adjusts Price Target on Humana to $342 From $400
Humana Analyst Ratings
Cantor Fitzgerald Reiterates Neutral on Humana, Maintains $395 Price Target
Humana Is Maintained at Outperform by RBC Capital
Humana Analyst Ratings
Update: RBC Raises Price Target on Humana to $400 From $385, Maintains Outperform Rating
RBC Capital Maintains Humana(HUM.US) With Buy Rating, Raises Target Price to $400
Wells Fargo Maintains Humana(HUM.US) With Buy Rating, Maintains Target Price $387
Wells Fargo Remains a Buy on Humana (HUM)
Humana Analyst Ratings
JPMorgan Adjusts Price Target on Humana to $396 From $332, Maintains Neutral Rating
Humana Analyst Ratings
Cantor Fitzgerald Reiterates Neutral on Humana, Maintains $395 Price Target
Wells Fargo Raises Humana's Price Target to $387 From $350
Analysts' Top Healthcare Picks: Laboratory (LH), Humana (HUM)
Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Evolus (EOLS) and Humana (HUM)
Humana Analyst Ratings
Deutsche Bank Maintains Hold on Humana, Raises Price Target to $349
TD Cowen Maintains Humana(HUM.US) With Buy Rating, Cuts Target Price to $402